Abstract
A pH- and GSH-responsive 1H/19F dual-mode magnetic resonance imaging contrast agent (MRI CA) was constructed by incorporating MnOx into Zr-based MOF nanoparticles (MnOx/UiO-66-F/PPEG NPs) with an organic ligand of tetrafluoro-terephthalic acid (F4PTA). Under a weak acidic tumor micro-environment, MnOx/UiO-66-F/PPEG NPs would collapse to release MnOx and free F4PTA. Due to the released free F4PTA, 19F MRI signal was enhanced. Meanwhile, GSH, which is overexpressed in a tumor micro-environment, reduced MnOx to divalent manganese ions and improved the T1-weighted MR imaging capability. As a proof of concept, MnOx/UiO-66-F/PPEG NPs was favorable for dual 1H/19F MRI with a high signal-to-noise ratio in vivo.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
